The Altec Styslinger Genomic Medicine and Data Sciences Building will help cement UAB’s place as a leading research institution in genomic and precision medicine.
Partnership with the PathCheck Foundation, founded at MIT in Cambridge, Ma., will enable other states and countries to use UAB-created exposure verification technology for exposure notification.
The partnership pairs the company's technical and operational expertise with UAB Medicine's clinical expertise as a national leader in pulmonary and critical care medicine.
Project ECHO links medical professionals with an expert in a particular field in an interactive video format to boost learning and, ultimately, patient care.
Cancer centers nationwide, including the O’Neal Comprehensive Cancer Center at UAB as a leading site, are joining together to address the impact of COVID-19 pandemic on cancer prevention and treatment.
There is a narrow window of opportunity for successfully treating major cardiovascular events, and patients risk serious consequences if they wait for symptoms to get worse before seeking medical attention.
UAB is an Equal Employment/Equal Educational Opportunity Institution dedicated to providing equal opportunities and equal access to all individuals regardless of race, color, religion, ethnic or national origin, sex (including pregnancy), genetic information, age, disability, religion, sexual orientation, gender identity, gender expression, and veteran’s status. As required by Title IX, UAB prohibits sex discrimination in any education program or activity that it operates. Individuals may report concerns or questions to UAB’s Assistant Vice President and Senior Title IX Coordinator. The Title IX notice of nondiscrimination is located at uab.edu/titleix.